» Articles » PMID: 11343988

Outcome of Heart Transplantation in Patients Previously Infected with Hepatitis C Virus

Overview
Publisher Elsevier
Date 2001 May 10
PMID 11343988
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The lack of knowledge about the course of hepatitis C virus infection (HCV) before heart transplantation (HTx) prompted us to describe our experience with 4 such patients who presented with positive HCV serology before surgery. Two experienced non-liver related deaths at 3.5 and 5 years after HTx, and none of the patients developed signs of hepatic insufficiency during the follow-up (mean 3.8 years). Tests for HCV antibodies were frequently negative, whereas viral RNA was detected in 81% of the measurements, showing that virus detection techniques seem to be more sensitive than serology techniques in detecting HCV infection in this group of patients. Although immunosuppression promotes active HCV replication, it does not seem to change the chronic features of HCV infection during the first years in patients with good liver function.

Citing Articles

Heart Transplantation Outcomes in Patients With Hepatitis C Virus Infection: Potential Impact of Newer Antiviral Treatments After Transplantation.

Quader M, Wolfe L, Katlaps G, Lewis N, Kasirajan V Fed Pract. 2019; 34(Suppl 4):S40-S48.

PMID: 30766309 PMC: 6375473.


Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity.

Lee I, Localio R, Brensinger C, Blumberg E, Lautenbach E, Gasink L J Heart Lung Transplant. 2011; 30(11):1266-74.

PMID: 21764330 PMC: 3223534. DOI: 10.1016/j.healun.2011.06.003.


Treatment of hepatitis C in solid organ transplantation.

Chan S, Schwartz J, Rosen H Drugs. 2004; 64(5):489-98.

PMID: 14977386 DOI: 10.2165/00003495-200464050-00003.